The development of life-threatening cancer metastases at distant organs requires disseminated tumor cells’ adaptation to, and co-evolution with, the drastically different microenvironments of metastatic sites.
Cancer cells of common origin manifest distinct gene expression patterns after metastasizing to different organs. Clearly, the dynamic interaction between metastatic tumor cells and extrinsic signals at individual metastatic organ sites critically effects the subsequent metastatic outgrowth. Yet, it is unclear when and how disseminated tumor cells acquire the essential traits from the microenvironment of metastatic organs that prime their subsequent outgrowth.
Scientists show that both human and mouse tumor cells with normal expression of PTEN, an important tumor suppressor, lose PTEN expression after dissemination to the brain, but not to other organs. The PTEN level in PTEN-loss brain metastatic tumor cells is restored after leaving the brain microenvironment.
This brain microenvironment-dependent, reversible PTEN messenger RNA and protein downregulation is epigenetically regulated by microRNAs from brain astrocytes. Mechanistically, astrocyte-derived exosomes mediate an intercellular transfer of PTEN-targeting microRNAs to metastatic tumor cells, while astrocyte-specific depletion of PTEN-targeting microRNAs or blockade of astrocyte exosome secretion rescues the PTEN loss and suppresses brain metastasis in vivo.
Furthermore, this adaptive PTEN loss in brain metastatic tumor cells leads to an increased secretion of the chemokine CCL2, which recruits IBA1-expressing myeloid cells that reciprocally enhance the outgrowth of brain metastatic tumor cells via enhanced proliferation and reduced apoptosis.
These findings demonstrate a remarkable plasticity of PTEN expression in metastatic tumor cells in response to different organ microenvironments, underpinning an essential role of co-evolution between the metastatic cells and their microenvironment during the adaptive metastatic outgrowth.
These findings signify the dynamic and reciprocal cross-talk between tumor cells and the metastatic niche; importantly, they provide new opportunities for effective anti-metastasis therapies, especially of consequence for brain metastasis patients.
http://www.nature.com/nature/journal/v527/n7576/full/nature15376.html
PTEN and brain tumor metastasis
- 3,170 views
- Added
Edited
Latest News
Signaling mechanism in live…
By newseditor
Posted 05 Jun
Statin prevents cancer deve…
By newseditor
Posted 05 Jun
Predicting recovery in pati…
By newseditor
Posted 05 Jun
Astrocytes induce sex-speci…
By newseditor
Posted 04 Jun
Human cervix modeled in mic…
By newseditor
Posted 04 Jun
Other Top Stories
Restoring breathing, partial forelimb function in rats with spinal…
Read more
Strength in synaptic connections regulate reward and depression beh…
Read more
How a small molecule promotes removal of excess cholesterol
Read more
RNA snippets accumulation in brain cells in aging
Read more
Why older women are less healthy than older men
Read more
Protocols
Clinical and CSF single-cel…
By newseditor
Posted 05 Jun
ChatGPT-assisted deep learn…
By newseditor
Posted 04 Jun
Turning the tide in aggress…
By newseditor
Posted 03 Jun
Mapping medically relevant…
By newseditor
Posted 01 Jun
Accessible high-speed image…
By newseditor
Posted 30 May
Publications
BCAA-nitrogen flux in brown…
By newseditor
Posted 05 Jun
Mitochondrial GRIM19 Loss I…
By newseditor
Posted 05 Jun
Cofilactin rod formation me…
By newseditor
Posted 05 Jun
Targeting ATP2B1 impairs PI…
By newseditor
Posted 05 Jun
Statin prevents cancer deve…
By newseditor
Posted 05 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar